Your browser doesn't support javascript.
loading
Identifying regulators of aberrant stem cell and differentiation activity in colorectal cancer using a dual endogenous reporter system.
Spisak, Sandor; Chen, David; Likasitwatanakul, Pornlada; Doan, Paul; Li, Zhixin; Bala, Pratyusha; Vizkeleti, Laura; Tisza, Viktoria; De Silva, Pushpamali; Giannakis, Marios; Wolpin, Brian; Qi, Jun; Sethi, Nilay S.
  • Spisak S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Chen D; Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.
  • Likasitwatanakul P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Doan P; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Li Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Bala P; Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Vizkeleti L; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard University, Cambridge, MA, USA.
  • Tisza V; Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • De Silva P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Giannakis M; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard University, Cambridge, MA, USA.
  • Wolpin B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Qi J; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard University, Cambridge, MA, USA.
  • Sethi NS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Nat Commun ; 15(1): 2230, 2024 Mar 12.
Article en En | MEDLINE | ID: mdl-38472198
ABSTRACT
Aberrant stem cell-like activity and impaired differentiation are central to the development of colorectal cancer (CRC). To identify functional mediators of these key cellular programs, we engineer a dual endogenous reporter system by genome-editing the SOX9 and KRT20 loci of human CRC cell lines to express fluorescent reporters, broadcasting aberrant stem cell-like and differentiation activity, respectively. By applying a CRISPR screen targeting 78 epigenetic regulators with 542 sgRNAs to this platform, we identify factors that contribute to stem cell-like activity and differentiation in CRC. Perturbation single cell RNA sequencing (Perturb-seq) of validated hits nominate SMARCB1 of the BAF complex (also known as SWI/SNF) as a negative regulator of differentiation across an array of neoplastic colon models. SMARCB1 is a dependency and required for in vivo growth of human CRC models. These studies highlight the utility of biologically designed endogenous reporter platforms to uncover regulators with therapeutic potential.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / ARN Guía de Sistemas CRISPR-Cas Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / ARN Guía de Sistemas CRISPR-Cas Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article